سعر كيموكستين 60 مجم 10 كبسولات 2022

Kemoxetin atomoxetine 60 mg capsules, pack of 10, by Chemipharm (Egypt), used for attention-deficit/hyperactivity disorder.

• Treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and pediatric patients 6 years and older, as part of a total treatment program.Population: Adults and children 6 years and olderDailyMed (U.S. National Library of Medicine)

• Most common in children: nausea, vomiting, fatigue, decreased appetite, abdominal pain and somnolence. Most common in adults: constipation, dry mouth, nausea, decreased appetite, dizziness, erectile dysfunction and urinary hesitation.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to atomoxetine or other constituents.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Use with, or within 14 days of stopping, a monoamine oxidase inhibitor (MAOI).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Narrow-angle glaucoma; pheochromocytoma or history of it; severe cardiac or vascular disorders that would deteriorate with clinically important increases in blood pressure or heart rate.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: increased risk of suicidal ideation in pediatric patients 6 years and older; monitor closely for suicidal thoughts, clinical worsening or unusual behaviour, especially early in therapy and after dose changes.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Severe liver injury has been reported; discontinue and do not restart in patients with jaundice or laboratory evidence of liver injury.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• May increase blood pressure and heart rate; use with caution in hypertension, tachycardia or cardiovascular/cerebrovascular disease.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Monoamine oxidase inhibitors (including linezolid, IV methylene blue)Contraindicated: serious, sometimes fatal reactions have been reported with concomitant use or within 14 days of stopping an MAOI.DailyMed (U.S. National Library of Medicine)
• Strong CYP2D6 inhibitors (e.g. paroxetine, fluoxetine, quinidine)Increase atomoxetine exposure; use a longer titration interval (4 weeks) if symptoms fail to improve.DailyMed (U.S. National Library of Medicine)

• Available data in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or adverse outcomes; some animal studies showed adverse developmental outcomes.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• No data on presence in human milk; atomoxetine is present in animal milk. Weigh breastfeeding benefits against the mother's need for the drug and potential effects on the infant.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Atomoxetine: Selectively inhibits the presynaptic norepinephrine transporter; the exact mechanism of its ADHD effect is unknown.